Nuechterlein Carole

Nuechterlein Carole is listed in filings as Director at Aligos Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 26, 2025, including 2 public disclosures. Recent filings connect the profile to Aligos Therapeutics, Inc. (ALGS). The current snapshot covers public activity from Jun 28, 2024 to Jun 26, 2025. Reported amounts are shown as $22.8K to $44.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.